Recommendations for fertility preservation in patients with lymphoma, leukemia, and breast cancer

S. Samuel Kim, Jacques Donnez, Pedro Barri, Antonio Pellicer, Pasquale Patrizio, Zev Rosenwaks, Peter Nagy, Tommaso Falcone, Claus Andersen, Outi Hovatta, Hamish Wallace, Dror Meirow, Debra Gook, Seok H. Kim, Chii Ruey Tzeng, Shuetu Suzuki, Bunpei Ishizuka, Marie Madeleine Dolmans

Research output: Contribution to journalArticle

121 Citations (Scopus)

Abstract

Fertility issues should be addressed to all patients in reproductive age before cancer treatment. In men, cryopreservation of sperm should be offered to all cancer patients in reproductive age regardless of the risk of gonadal failure. In women, the recommendation of fertility preservation should be individualized based on multiple factors such as the urgency of treatment, the age of the patient, the marital status, the regimen and dosage of cancer treatment.

Original languageEnglish
Pages (from-to)465-468
Number of pages4
JournalJournal of Assisted Reproduction and Genetics
Volume29
Issue number6
DOIs
Publication statusPublished - Jun 2012

Fingerprint

Fertility Preservation
Lymphoma
Leukemia
Breast Neoplasms
Neoplasms
Cryopreservation
Marital Status
Fertility
Spermatozoa
Therapeutics

Keywords

  • Breast cancer
  • Cancer
  • Cancer survival
  • Chemotherapy
  • Fertility
  • Fertility preservation
  • GnRH agonist
  • Gonadal failure
  • Leukemia
  • Lymphoma
  • Oocyte cryopreservation
  • Ovarian tissue cryopreservation
  • Primary ovarian insufficiency

ASJC Scopus subject areas

  • Obstetrics and Gynaecology
  • Reproductive Medicine
  • Developmental Biology
  • Genetics
  • Genetics(clinical)

Cite this

Kim, S. S., Donnez, J., Barri, P., Pellicer, A., Patrizio, P., Rosenwaks, Z., ... Dolmans, M. M. (2012). Recommendations for fertility preservation in patients with lymphoma, leukemia, and breast cancer. Journal of Assisted Reproduction and Genetics, 29(6), 465-468. https://doi.org/10.1007/s10815-012-9786-y

Recommendations for fertility preservation in patients with lymphoma, leukemia, and breast cancer. / Kim, S. Samuel; Donnez, Jacques; Barri, Pedro; Pellicer, Antonio; Patrizio, Pasquale; Rosenwaks, Zev; Nagy, Peter; Falcone, Tommaso; Andersen, Claus; Hovatta, Outi; Wallace, Hamish; Meirow, Dror; Gook, Debra; Kim, Seok H.; Tzeng, Chii Ruey; Suzuki, Shuetu; Ishizuka, Bunpei; Dolmans, Marie Madeleine.

In: Journal of Assisted Reproduction and Genetics, Vol. 29, No. 6, 06.2012, p. 465-468.

Research output: Contribution to journalArticle

Kim, SS, Donnez, J, Barri, P, Pellicer, A, Patrizio, P, Rosenwaks, Z, Nagy, P, Falcone, T, Andersen, C, Hovatta, O, Wallace, H, Meirow, D, Gook, D, Kim, SH, Tzeng, CR, Suzuki, S, Ishizuka, B & Dolmans, MM 2012, 'Recommendations for fertility preservation in patients with lymphoma, leukemia, and breast cancer', Journal of Assisted Reproduction and Genetics, vol. 29, no. 6, pp. 465-468. https://doi.org/10.1007/s10815-012-9786-y
Kim, S. Samuel ; Donnez, Jacques ; Barri, Pedro ; Pellicer, Antonio ; Patrizio, Pasquale ; Rosenwaks, Zev ; Nagy, Peter ; Falcone, Tommaso ; Andersen, Claus ; Hovatta, Outi ; Wallace, Hamish ; Meirow, Dror ; Gook, Debra ; Kim, Seok H. ; Tzeng, Chii Ruey ; Suzuki, Shuetu ; Ishizuka, Bunpei ; Dolmans, Marie Madeleine. / Recommendations for fertility preservation in patients with lymphoma, leukemia, and breast cancer. In: Journal of Assisted Reproduction and Genetics. 2012 ; Vol. 29, No. 6. pp. 465-468.
@article{e455758f20e740f5978d1b8960db605a,
title = "Recommendations for fertility preservation in patients with lymphoma, leukemia, and breast cancer",
abstract = "Fertility issues should be addressed to all patients in reproductive age before cancer treatment. In men, cryopreservation of sperm should be offered to all cancer patients in reproductive age regardless of the risk of gonadal failure. In women, the recommendation of fertility preservation should be individualized based on multiple factors such as the urgency of treatment, the age of the patient, the marital status, the regimen and dosage of cancer treatment.",
keywords = "Breast cancer, Cancer, Cancer survival, Chemotherapy, Fertility, Fertility preservation, GnRH agonist, Gonadal failure, Leukemia, Lymphoma, Oocyte cryopreservation, Ovarian tissue cryopreservation, Primary ovarian insufficiency",
author = "Kim, {S. Samuel} and Jacques Donnez and Pedro Barri and Antonio Pellicer and Pasquale Patrizio and Zev Rosenwaks and Peter Nagy and Tommaso Falcone and Claus Andersen and Outi Hovatta and Hamish Wallace and Dror Meirow and Debra Gook and Kim, {Seok H.} and Tzeng, {Chii Ruey} and Shuetu Suzuki and Bunpei Ishizuka and Dolmans, {Marie Madeleine}",
year = "2012",
month = "6",
doi = "10.1007/s10815-012-9786-y",
language = "English",
volume = "29",
pages = "465--468",
journal = "Journal of Assisted Reproduction and Genetics",
issn = "1058-0468",
publisher = "Springer New York",
number = "6",

}

TY - JOUR

T1 - Recommendations for fertility preservation in patients with lymphoma, leukemia, and breast cancer

AU - Kim, S. Samuel

AU - Donnez, Jacques

AU - Barri, Pedro

AU - Pellicer, Antonio

AU - Patrizio, Pasquale

AU - Rosenwaks, Zev

AU - Nagy, Peter

AU - Falcone, Tommaso

AU - Andersen, Claus

AU - Hovatta, Outi

AU - Wallace, Hamish

AU - Meirow, Dror

AU - Gook, Debra

AU - Kim, Seok H.

AU - Tzeng, Chii Ruey

AU - Suzuki, Shuetu

AU - Ishizuka, Bunpei

AU - Dolmans, Marie Madeleine

PY - 2012/6

Y1 - 2012/6

N2 - Fertility issues should be addressed to all patients in reproductive age before cancer treatment. In men, cryopreservation of sperm should be offered to all cancer patients in reproductive age regardless of the risk of gonadal failure. In women, the recommendation of fertility preservation should be individualized based on multiple factors such as the urgency of treatment, the age of the patient, the marital status, the regimen and dosage of cancer treatment.

AB - Fertility issues should be addressed to all patients in reproductive age before cancer treatment. In men, cryopreservation of sperm should be offered to all cancer patients in reproductive age regardless of the risk of gonadal failure. In women, the recommendation of fertility preservation should be individualized based on multiple factors such as the urgency of treatment, the age of the patient, the marital status, the regimen and dosage of cancer treatment.

KW - Breast cancer

KW - Cancer

KW - Cancer survival

KW - Chemotherapy

KW - Fertility

KW - Fertility preservation

KW - GnRH agonist

KW - Gonadal failure

KW - Leukemia

KW - Lymphoma

KW - Oocyte cryopreservation

KW - Ovarian tissue cryopreservation

KW - Primary ovarian insufficiency

UR - http://www.scopus.com/inward/record.url?scp=84864951338&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864951338&partnerID=8YFLogxK

U2 - 10.1007/s10815-012-9786-y

DO - 10.1007/s10815-012-9786-y

M3 - Article

C2 - 22648282

AN - SCOPUS:84864951338

VL - 29

SP - 465

EP - 468

JO - Journal of Assisted Reproduction and Genetics

JF - Journal of Assisted Reproduction and Genetics

SN - 1058-0468

IS - 6

ER -